SARS-CoV-2 (Covid-19): A short update on molecular biochemistry, pathology, diagnosis and therapeutic strategies
- PMID: 33478237
- DOI: 10.1177/0004563221992390
SARS-CoV-2 (Covid-19): A short update on molecular biochemistry, pathology, diagnosis and therapeutic strategies
Abstract
The ongoing coronavirus (covid-19) pandemic highlights the need for global scientific cooperation to advance our understanding of the immunological, molecular and biochemical mechanisms causing infection by this virus. Better understanding of key processes has allowed the development of vaccines in record time, and of agents with the potential to treat and neutralize current and future coronavirus outbreaks. To date, clinically effective agents for prevention and treatment of covid-19 infections are limited. This review provides a brief synopsis regarding the molecular biology, pathology and laboratory tests commonly used in the diagnosis and prognosis of covid-19, as well as the development of vaccines and therapeutic strategies to manage its current and future mutations.
Keywords: Coronavirus; Covid-19; SARS-CoV-2; therapy; treatment; vaccine.
Similar articles
-
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E. J Biol Regul Homeost Agents. 2021. PMID: 33377359
-
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949. Cells. 2021. PMID: 34831172 Free PMC article. Review.
-
Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).Toxicol Pathol. 2020 Oct;48(7):800-809. doi: 10.1177/0192623320959090. Epub 2020 Sep 14. Toxicol Pathol. 2020. PMID: 32926660 Review.
-
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25. Vaccine. 2020. PMID: 32507409 Free PMC article.
-
An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.J Basic Clin Physiol Pharmacol. 2020 Sep 14;31(6). doi: 10.1515/jbcpp-2020-0113. J Basic Clin Physiol Pharmacol. 2020. PMID: 32924964
Cited by
-
Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review.J Nanopart Res. 2023;25(3):43. doi: 10.1007/s11051-023-05690-w. Epub 2023 Feb 27. J Nanopart Res. 2023. PMID: 36875184 Free PMC article. Review.
-
Radiological Findings Increased the Successful of COVID-19 Diagnosis in Hospitalized Patients Suspected of Respiratory Viral Infection but with a Negative First SARS-CoV-2 RT-PCR Result.Diagnostics (Basel). 2022 Mar 11;12(3):687. doi: 10.3390/diagnostics12030687. Diagnostics (Basel). 2022. PMID: 35328241 Free PMC article.
-
Identification of potential inhibitors of omicron variant of SARS-Cov-2 RBD based virtual screening, MD simulation, and DFT.Front Chem. 2022 Dec 8;10:1063374. doi: 10.3389/fchem.2022.1063374. eCollection 2022. Front Chem. 2022. PMID: 36569957 Free PMC article.
-
Determining the Health Problems Experienced by Young Adults in Turkey, Who Received the COVID-19 Vaccine.Vaccines (Basel). 2022 Sep 14;10(9):1526. doi: 10.3390/vaccines10091526. Vaccines (Basel). 2022. PMID: 36146604 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous